Article Cited by others

MOLECULES OF THE MILLENNIUM

Asenapine, a new sublingual atypical antipsychotic

Balaraman R, Gandhi Hardik

Year : 2010| Volume: 1| Issue : 1 | Page no: 60-61

   This article has been cited by
 
1 Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice
Zackary A. Cope, Johnny A. Kenton, Arpi Minassian, Maureen V. Martin, William Perry, Christoffer Bundgaard, Jørn Arnt, Jordy van Enkhuizen, Mark A. Geyer, Jared W. Young
Behavioural Brain Research. 2021; 405: 113167
[Pubmed]  [Google Scholar] [DOI]
2 Recent advances in the development of asenapine formulations
Akhil Suresh, Reema Narayan, Usha Y Nayak
Expert Opinion on Drug Delivery. 2020; 17(10): 1377
[Pubmed]  [Google Scholar] [DOI]
3 Controlled Parenteral Formulations: An Efficacious and Favourable Way to Deliver the Anti-psychotic Drugs
Harshita Gupta, Rutu Panchal, Niyati Acharya, Priti Jignesh Mehta
Current Psychiatry Research and Reviews. 2020; 16(1): 42
[Pubmed]  [Google Scholar] [DOI]
4 Atypical antipsychotics: trends in analysis and sample preparation of various biological samples
Domniki Fragou, Spyridoula Dotsika, Parthena Sarafidou, Victoria Samanidou, Samuel Njau, Leda Kovatsi
Bioanalysis. 2012; 4(8): 961-980
[Pubmed]  [Google Scholar] [DOI]
5 Therapeutic drug monitoring of common antipsychotics
Patteet, L. and Morrens, M. and Maudens, K.E. and Niemegeers, P. and Sabbe, B. and Neels, H.
Therapeutic Drug Monitoring. 2012; 34(6): 629-651
[Pubmed]  [Google Scholar]
6 Asenapina — nowy atypowy lek przeciwpsychotyczny Asenapine — a new atypical antipsychotic
A Wysokiński, I Kłoszewska
Psychiatry. 2012; 9(1): 27-35
[HTML Full text]  [Google Scholar]
7 Therapeutic Drug Monitoring of Common Antipsychotics
Lisbeth Patteet,Manuel Morrens,Kristof E. Maudens,Peter Niemegeers,Bernard Sabbe,Hugo Neels
Therapeutic Drug Monitoring. 2012; 34(6): 629
[Pubmed]  [Google Scholar] [DOI]
8 Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management
Levine M, Ruha AM.
CNS Drugs. 2012 Jul 1;26(7):601-11. 2012; 26(7): 601-611
[Pubmed]  [Google Scholar] [DOI]

 

Read this article